An interventional study of Girls in Sexual Health, Mobile Application and Female Adolescents, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Completed at 1 site in Taiwan. Open to female participants aged 15 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-02.
Sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital · Not applicable, Interventional, and Health services research
Adolescents' sexual health has been an important issue for health care professionals, education and society. The purpose of this study was to examine the impact of a mobile application on adolescent girls' sexual communication self-efficacy and sexual health outcomes. A total of 245 adolescent girls were recruited through purposive sampling between November 2020 and July 2021, with 133 in the experimental group and 112 in the control group. Data were collected at three time points: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2).
Adolescents' sexual health has been an important issue for healthcare professionals, educators, and society. Conversations about sexual health are often sensitive and uncomfortable for young people. This is especially true for adolescent girls, who often struggle to assert their sexual desires or preferences in relationships. Empowering young women with communication and negotiation skills during sexual encounters is therefore crucial. To address this, we developed a sexual communication program based on the ADDIE instructional design model. The purpose of this study was to examine the impact of a mobile application on adolescent girls' sexual communication self-efficacy and sexual health outcomes. A total of 245 emerging adult women were recruited through purposive sampling between November 2020 and July 2021, with 133 in the experimental group and 112 in the control group. The experimental group received the sexual communication program, while the control group received routine care. Data were collected at three time points: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2).
719 studies on the registry are indexed under Communication; 159 are open to participants now.
This study's enrollment of 245 is above the median of 144 across 571 interventional studies indexed under Communication.
Browse Communication studies →Kaohsiung Medical University Chung-Ho Memorial Hospital is the lead sponsor of 291 studies on the registry; 58 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
∙ individuals who are homosexual or have an uncertain sexual orientation.
mobile application
Behavioral: Girls
routine care
mobile application
sexual communication self-efficacy
The "Sexual Communication Self-Efficacy Scale" developed by Quinn-Nilas et al. (2016), including five factors: contraception communication, positive sexual messages, negative sexual messages, sexual history, and condom negotiation. The scale has 22 items, with scores ranging from 1 to 4. The higher the score, the more confident the respondent in communicating sexual issues with their partner.
Time frame: baseline (T0), immediately after the 6-week intervention (T1), and 4 weeks post-intervention (T2)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2020 to primary completion in May 2021, 6 months.
Of 390 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 6 months is below that.
Counting every sponsor, half of 394 studies reached it within 18 months; a quarter within 6 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kaohsiung Medical University Chung-Ho Memorial Hospital →